Abstract:High throughput screening methods have driven a paradigm shift in biopharmaceutical development by reducing the costs of good manufactured (COGM) and accelerate the launch to market of novel drug products. Scale-down cell culture systems such as shaken 24- and 96-deep-well plates (DWPs) are used for initial screening of hundreds of recombinant mammalian clonal cell lines to quickly and efficiently select the best producing strains expressing product quality attributes that fit to industry platform. A common modification monitored from early-stage product development is protein aggregation due to its impact on safety and efficacy. This study aims to integrate high-throughput analysis of aggregation-prone therapeutic proteins with 96-deep well plate screening to rank clones based on the aggregation levels of the expressed proteins. Here we present an automated, small-scale analytical platform workflow combining the purification and subsequent aggregation analysis of protein biopharmaceuticals expressed in 96-DWP cell cultures. Product purification was achieved by small-scale solid-phase extraction using dual flow chromatography (DFC) automated on a robotic liquid handler for the parallel processing of up to 96 samples at a time. At-line coupling of size-exclusion chromatography (SEC) using a 2.1 mm ID column enabled the detection of aggregates with sub-2 µg sensitivity and a 3.5 min run time. The entire workflow was designed as an application to aggregation-prone mAbs and "mAb-like" next generation biopharmaceuticals, such as bispecific antibodies (BsAbs). Application of the high-throughput analytical workflow to a shake plate overgrow (SPOG) screen, enabled the screening of 384 different clonal cell lines in 32 h, requiring < 2 μg of protein per sample. Aggregation levels expressed by the clones varied between 9 and 76%. This high-throughput analytical workflow allowed for the early elimination of clonal cell lines with high aggregation, demonstrating the advantage of integrating analytical testing for critical quality attributes (CQAs) earlier in product development to drive better decision making.

Enabling high-throughput enzyme discovery and engineering with a low-cost, robot-assisted pipeline

Ultrahigh-Throughput Enzyme Engineering and Discovery in In Vitro Compartments

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost

Development of a full-length human protein production pipeline

High-throughput protein expression screening and purification in Escherichia coli

Open-source milligram-scale, four channel, automated protein purification system

Cell-free Directed Evolution of a Protease in Microdroplets at Ultrahigh Throughput

Streamlined Protein Expression and Purification Using Cleavable Self-Aggregating Tags

Automation to Enable High-Throughput Chemical Proteomics

A high-performance protein preparation approach in a single column-free step

Computational Enzyme Engineering Pipelines for Optimized Production of Renewable Chemicals

Automating the Purification and Isolation of Synthetic DNA

Low-N protein engineering with data-efficient deep learning

Protein formulation through automated screening of pH and buffer conditions, using the Robotein® high throughput facility

Automated high throughput workflow for rapid implementation of immobilized enzymes in chemical process development

Automation of protein purification for structural genomics

An automated, low volume, and high-throughput analytical platform for aggregate quantitation from cell culture media

A High-Throughput Screening Platform for Engineering Poly(ethylene Terephthalate) Hydrolases

A fast and simple automated multi-step protein purification method for ÄKTA go systems

Biofoundry-assisted expression and characterization of plant proteins